Komori
Veritas In Silico (130A) · RiskMitigated

Risks Related to Patent Acquisition and Maintenance and Third-Party IP Disputes

First written in FY2023. 1 of 2 entries say "Mitigated", first in FY2025. Latest entry: FY2025.

2entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY20232024: 120242025: 020252026: 12026
Same theme, other companies
Acquisition and validity of the company's intellectual property rights, and risk of infringement lawsuits by third partiesA theme 66 companies write about · 66 as a headwind · 0 as a tailwind

9 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 66 companies compared. The sentences above are computed from all 66.
Full recordFilings, disclosures and news, newest first
  1. FY2025MitigatedAnnual report

    「Our drug-discovery platform provides a one-stop suite of technologies required for mRNA-targeted drug discovery. In particular, it can discover substructures on mRNA suitable for drug discovery and define target structures for any gene in high demand among pharmaceutical companies. We have obtained patents in Japan, the United States and Europe.」

    Patent protection has expanded to Japan, the United States and Europe, strengthening intellectual property protection. However, the risks of future failure to obtain patents or invalidation continue to be disclosed.
  2. FY2023First statedAnnual report

    「We are applying for and obtaining intellectual property rights, including patents, necessary for our business operations. However, not all intellectual property currently under application will necessarily be registered. Even after registration, rights may be partially or entirely invalidated through opposition proceedings or requests for invalidation trials.」

    The company identifies non-registration of applications, invalidation after registration, and the impact of third-party infringement claims and disputes on the business as risks.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Veritas In Silico yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.